US stocks SONN pre-market rise over 270%, announced the establishment of "HYPE version of micro strategy" holding 12.6 million HYPE and 300 million cash.
BlockBeats news, on July 14, the stock price of the US-listed company Sonnet BioTherapeutics Holdings, Inc. (SONN) rose 273.11% in pre-market trading, with a pre-market trading price of $19.29, an increase of $14.05 compared to the previous trading price. BlockBeats previously reported that the US-listed company Sonnet will merge to form Hyperliquid Strategies and initiate a treasury strategy, holding 12.6 million HYPE and $300 million in cash.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
US stocks SONN pre-market rise over 270%, announced the establishment of "HYPE version of micro strategy" holding 12.6 million HYPE and 300 million cash.
BlockBeats news, on July 14, the stock price of the US-listed company Sonnet BioTherapeutics Holdings, Inc. (SONN) rose 273.11% in pre-market trading, with a pre-market trading price of $19.29, an increase of $14.05 compared to the previous trading price. BlockBeats previously reported that the US-listed company Sonnet will merge to form Hyperliquid Strategies and initiate a treasury strategy, holding 12.6 million HYPE and $300 million in cash.